Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Francia, Giulio

One or more keywords matched the following items that are connected to Francia, Giulio

Item Type	Name
Academic Article	Development of a resistance-like phenotype to sorafenib by human hepatocellular carcinoma cells is reversible and can be delayed by metronomic UFT chemotherapy.
Academic Article	Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide.
Academic Article	Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy.
Academic Article	Resistance to metronomic chemotherapy and ways to overcome it.
Academic Article	Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents.
Academic Article	Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts.
Academic Article	Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapy.
Concept	Drug Resistance, Neoplasm
Academic Article	Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents.
Academic Article	Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib.

Search Criteria

Drug Resistance Neoplasm

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support